Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Tecan Group AG's earnings before interest and taxes (EBIT) for the
six
months ended in Jun. 2026 was MXN372 Mil.
Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2026 was MXN-2,402 Mil.
EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.
Tecan Group AG's annualizedROC % for the quarter that ended in Jun. 2026 was 2.05%.
Tecan Group AG's annualizedROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was 14.94%.
EBIT is also linked to Joel Greenblatt's definition of earnings yield.
Tecan Group AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was -4.80%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tecan Group AG EBIT Related Terms
Tecan Group AG EBIT Historical Data
* Premium members only.
The historical data trend for Tecan Group AG's EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Tecan Group AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tecan Group AG EV-to-EBIT vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Tecan Group AG's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Tecan Group AG's EV-to-EBIT falls into.
EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.
EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was MXN-2,402 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Tecan Group AG (MEX:TECN1N) has a EBIT of MXN-2,402 Mil as of Jun. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Tecan Group AG.
Is Tecan Group AG's EBIT too high?
Tecan Group AG's current EBIT is MXN-2,402 Mil. Overall, Tecan Group AG has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Tecan Group AG's EBIT compare to ISRG and BDX?
Tecan Group AG's EBIT of MXN-2,402 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Tecan Group AG. Tecan Group AG's current EBIT is MXN-2,402 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tecan Group AG stock overvalued right now?
Tecan Group AG (MEX:TECN1N) has a current EBIT of MXN-2,402 Mil. The stock's GF Value™ is MXN5,535.71, compared to a current price of MXN5,741.26 — trading 3.7% above its estimated fair value. The current EBIT is MXN-2,402 Mil. Tecan Group AG's overall GF Score™ is 74/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Tecan Group AG (MEX:TECN1N), the current EBIT is MXN-2,402 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tecan Group AG (MEX:TECN1N) Overvalued in 2026?
Based on GuruFocus' analysis, Tecan Group AG stock appears to be overvalued.
The current stock price of MXN5,741.26 is trading 3.7% above its estimated GF Value™ of MXN5,535.71.
Key valuation signals for MEX:TECN1N:
EBIT: MXN-2,402 Mil
GF Value™: MXN5,535.71 vs. price of MXN5,741.26 (3.7% above fair value)
No single metric tells the full story. See the MEX:TECN1N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tecan Group AG sells automated laboratory instruments and solutions for the diagnostics and life sciences research markets. The firm operates in two segments; The Life Sciences Business (end-customer business) segment supplies end users with automated workflow solutions directly. These solutions include laboratory instruments, software packages, application know-how, services, consumables, and spare parts, The partnering Business (OEM business) segment develops and manufactures OEM instruments and components that are distributed by partner companies under their names. A majority proportion of Tecan's revenue is generated in the Americas and Europe followed by Asia Specific.
74GF Score
Get the complete analysis for MEX:TECN1N
EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:TECN1N has been successfully added to your 
